PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS

• Alessio Maria Edoardo Maraglino,
• Viviana Amato,
• Federica Gigli,
• Simona Sammassimo,
• Rocco Pastano,
• Corrado Tarella,
• Elisabetta Todisco,
• Enrico Derenzini,
• Fabio Giglio

Affiliations

Alessio Maria Edoardo Maraglino

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Viviana Amato

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Federica Gigli

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Simona Sammassimo

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Rocco Pastano

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Corrado Tarella

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Elisabetta Todisco

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Enrico Derenzini

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy

Fabio Giglio

1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy